| Ytd | -78.09% | |
| 1y | -90.00% |
| Open | 1.60 | Prev Close | 1.62 | Low | 1.50 | High | 1.77 | Mkt Cap | 1.06M |
| Vol | 216.93K | Avg Vol | 832.36K | EPS | 28.07 | P/E | 0.06 | Forward P/E | N/A |
| Beta | 2.46 | Short Ratio | 0.09 | Inst. Own | 2.36% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 2.39 | 200-d Avg | 5.65 | 1yr Est | 700.00 |
SCNI News
Gainers Tempest Therapeutics (NASDAQ:TPST) stock increased by 41.6% to $1.07 during Tuesday's a
Gainers PDS Biotechnology (NASDAQ:PDSB) shares rose 63.7% to $0.65 during Tuesday's regular ses
Gainers Biodexa Pharmaceuticals (NASDAQ:BDRX) shares moved upwards by 39.3% to $1.56 during Tuesday
Veea shares surged 58% premarket on a NovaGen merger plan and $10M GeoNova investment, while other s
Gainers Basel Medical Group (NASDAQ:BMGL) shares moved upwards by 59.8% to $7.32 during Monday'
U.S. stocks fell Monday, led by a 2% tech decline. Nvidia may invest $10B in Anthropic; oil jumped 4
Gainers Scinai Immunotherapeutics (NASDAQ:SCNI) stock moved upwards by 44.6% to $2.4 during Monday&
Scholar Rock surged 11.9% after FDA approved ISEMBYLD for SMA; Scinai, Intercont and Rum led premark
Gainers Scinai Immunotherapeutics (NASDAQ:SCNI) shares rose 25.3% to $2.08 during Friday's afte
Gainers Gelteq (NASDAQ:GELS) shares increased by 38.6% to $0.97 during Thursday's pre-market se
Snowflake shares surged 24% after Q2 revenue and earnings beat estimates; other premarket gainers an
Gainers Gelteq (NASDAQ:GELS) stock moved upwards by 20.3% to $0.84 during Wednesday's after-mar
Investor webinar scheduled for August 26, 2026 at 11:00 a.m. EDTJERUSALEM, Aug. 24, 2026 /PRNewswire